NCT02657239 (MOVE UP) is a NA clinical trial of MOVE UP in Obesity, sponsored by University of Pittsburgh.

Who is sponsoring NCT02657239?

NCT02657239 is sponsored by University of Pittsburgh.

What drugs are being tested in NCT02657239?

Interventions in NCT02657239: MOVE UP.

Is NCT02657239 still recruiting?

NCT02657239 is currently completed. Last updated 14 January 2020.

Last reviewed 2020-01-14 · How we verify

NCT02657239: MOVE UP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobility & Vitality Lifestyle Program

Completed NA Last updated 14 January 2020

What this trial tests

NA trial testing MOVE UP in Obesity in 303 participants. Completed in 18 July 2019.

Timeline

4 May 2015

Primary endpoint
18 July 2019

18 July 2019

Quick facts

Lead sponsor	University of Pittsburgh
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	303
Start date	4 May 2015
Primary completion	18 July 2019
Estimated completion	18 July 2019
Sites	1 location across United States

Drugs / interventions tested

MOVE UP

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

University of Pittsburgh

Who can join

Adults 60 to 75, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MOVE UP is a weight management program for adults 60-75 in community settings led by trained community health workers.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Weight Loss through Lifestyle Intervention Improves Mobility in Older Adults.
Albert SM, Venditti EM, Boudreau RM, Kieffer LA, et al · · 2022 · cited 7× · PMID 33822933 · DOI 10.1093/geront/gnab048
Effectiveness of a behavioral lifestyle intervention on weight management and mobility improvement in older informal caregivers: a secondary data analysis.
Liu X, King J, Boak B, Danielson ME, et al · · 2022 · cited 4× · PMID 35902809 · DOI 10.1186/s12877-022-03315-w

Verify or expand the search:

Other trials of MOVE UP

Trials testing the same drug.

NCT03967912 — MOVE UP Lifestyle Intervention for Caregivers · NA · completed
NCT03963830 — Sustainability of MOVE UP Lifestyle Intervention · NA · completed

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of Pittsburgh trials

Trials by the same sponsor.

NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02657239 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 14 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02657239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing